Collaborative Advantage For All The Parties
APHARMA AUDIT endeavors to consolidate all available resources, fostering a Collaborative Advantage that proves advantageous to all stakeholders. This approach not only saves valuable time, reduces efforts, and minimizes the associated travel and auditing expenses for clients, specifically pharmaceutical companies and marketing authorization (MA) holders, but also alleviates suppliers from the onus of accommodating numerous customer audits. This, in turn, prevents the unnecessary depletion of time, resources, and disruptions to planned production.
The initiative extends its benefits to regulatory authorities, providing them access to comprehensive audit reports compiled by qualified and certified quality auditors. This access instills confidence in the supplier qualification processes of the company, proving invaluable during regulatory inspections.